BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 32067134)

  • 41. Synthesis and anti-proliferation activity of mogrol derivatives bearing quinoline and triazole moieties.
    Song JR; Li N; Li DP
    Bioorg Med Chem Lett; 2021 Jun; 42():128090. PubMed ID: 33964443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel dibenzo[b,d]furan-1H-1,2,4-triazole derivatives: Synthesis and antitumor activity.
    Chen X; Shi YM; Huang C; Xia S; Yang LJ; Yang XD
    Anticancer Agents Med Chem; 2016; 16(3):377-86. PubMed ID: 26278547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1,2,3-Triazole Tagged 3H-Pyrano[2,3-d]pyrimidine-6-carboxylate Derivatives: Synthesis, in Vitro Cytotoxicity, Molecular Docking and DNA Interaction Studies.
    Boda SK; Pishka V; Lakshmi PVA; Chinde S; Grover P
    Chem Biodivers; 2018 Jun; 15(6):e18000101. PubMed ID: 29660245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
    Amujuri D; Siva B; Poornima B; Sirisha K; Sarma AVS; Lakshma Nayak V; Tiwari AK; Purushotham U; Suresh Babu K
    Eur J Med Chem; 2018 Apr; 149():182-192. PubMed ID: 29501940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design and synthesis of 1,2,3-triazolo linked benzo[d]imidazo[2,1-b]thiazole conjugates as tubulin polymerization inhibitors.
    Shaik SP; Vishnuvardhan MVPS; Sultana F; Subba Rao AV; Bagul C; Bhattacharjee D; Kapure JS; Jain N; Kamal A
    Bioorg Med Chem; 2017 Jul; 25(13):3285-3297. PubMed ID: 28462842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
    Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
    Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles.
    Yadav P; Lal K; Kumar A; Guru SK; Jaglan S; Bhushan S
    Eur J Med Chem; 2017 Jan; 126():944-953. PubMed ID: 28011424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.
    Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Pottoo FH; Jha M
    Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900262. PubMed ID: 32003485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M).
    Shaheen MA; El-Emam AA; El-Gohary NS
    Bioorg Chem; 2020 Dec; 105():104274. PubMed ID: 33339080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis and biological evaluation of homoerythrina alkaloid derivatives bearing a triazole moiety as PARP-1 inhibitors and as potential antitumor drugs.
    Li S; Li XY; Zhang TJ; Kamara MO; Liang JW; Zhu J; Meng FH
    Bioorg Chem; 2020 Jan; 94():103385. PubMed ID: 31669094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles.
    Mohammadi-Khanaposhtani M; Safavi M; Sabourian R; Mahdavi M; Pordeli M; Saeedi M; Ardestani SK; Foroumadi A; Shafiee A; Akbarzadeh T
    Mol Divers; 2015 Nov; 19(4):787-95. PubMed ID: 26170096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons.
    Halawa AH; Elgammal WE; Hassan SM; Hassan AH; Nassar HS; Ebrahim HY; Mehany ABM; El-Agrody AM
    Bioorg Chem; 2020 May; 98():103725. PubMed ID: 32199303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
    Lu GQ; Li XY; Mohamed O K; Wang D; Meng FH
    Eur J Med Chem; 2019 Jun; 171():282-296. PubMed ID: 30927565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR
    Gaber AA; Bayoumi AH; El-Morsy AM; Sherbiny FF; Mehany ABM; Eissa IH
    Bioorg Chem; 2018 Oct; 80():375-395. PubMed ID: 29986185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells.
    Khan I; Zaib S; Javed M; Rashid F; Iqbal J; Ibrar A
    Anticancer Agents Med Chem; 2021 Oct; 21(16):2181-2191. PubMed ID: 33573578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
    Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
    Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
    Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
    Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
    Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, Synthesis and Biological Evaluation of Novel 4-phenoxypyridine Derivatives Containing Semicarbazones Moiety as Potential c-Met Kinase Inhibitors.
    Li J; Li J; Zhang J; Shi J; Ding S; Liu Y; Chen Y; Liu J
    Anticancer Agents Med Chem; 2020; 20(5):559-570. PubMed ID: 31893997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulfamic acid promoted one-pot synthesis of phenanthrene fused-dihydrodibenzo-quinolinones: Anticancer activity, tubulin polymerization inhibition and apoptosis inducing studies.
    Kumar NP; Thatikonda S; Tokala R; Kumari SS; Lakshmi UJ; Godugu C; Shankaraiah N; Kamal A
    Bioorg Med Chem; 2018 May; 26(8):1996-2008. PubMed ID: 29525336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.